MannKind Corporation (NASDAQ:MNKD) fell 10.07% in pre-market trading to $3.
On April 6, analysts at Wedbush led by Liana Moussatos highlighted upcoming events in the biotech sector. Here is what to watch for: OvaScience Inc …
